| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $106.0M | +48.8% |
| SG&A Expense | $26.5M | +0.9% |
| Operating Income | -$152.0M | -109.6% |
| Interest Expense | $25K | -68.8% |
| Pre-tax Income | -$142.7M | -104.4% |
| Income Tax | $0 | — |
| Net Income | -$142.7M | -104.4% |
| EPS (Basic) | -$3.31 | -94.7% |
| EPS (Diluted) | -$3.31 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $159.7M | -38.0% |
| Current Assets | $162.3M | -37.8% |
| Total Assets | $207.3M | -37.3% |
| Current Liabilities | $19.3M | -2.1% |
| Total Liabilities | $37.1M | -3.2% |
| Stockholders' Equity | $170.2M | -41.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$93.7M | -109.4% |
| Capital Expenditures | $4.5M | -73.4% |
| Investing Cash Flow | -$4.5M | +73.4% |
| Financing Cash Flow | $236K | -99.4% |
| Free Cash Flow | -$98.2M | -59.5% |
| -94.7% |